HB 3552 makes narrowly targeted amendments to the statutory authorities that underpin federal reentry grant programs. The bill adds treatment of substance use disorders (including peer recovery services, case management, overdose education, and overdose reversal medications) and reentry housing services to the list of permitted activities in the State and Local Reentry Demonstration Projects, and it updates multiple cross‑references so several grant programs remain authorized into the late 2020s.
For practitioners, the bill keeps a set of Department of Justice grant programs alive on paper and explicitly directs reentry grantees to be able to fund addiction treatment and transitional housing components. It does not itself appropriate new money; rather, it changes what activities are permissible and extends the years during which those programs are statutorily authorized to receive appropriations.
At a Glance
What It Does
The bill amends 34 U.S.C. 10631(b) to add two new allowable activities for state and local reentry demonstration projects: treating substance use disorders (with enumerated services) and providing reentry housing services. It also replaces earlier year ranges in six statutory grant provisions so those programs are authorized for fiscal years 2026 through 2030.
Who It Affects
Primary implementers and applicants are DOJ grant recipients—state and local governments, nonprofit reentry service providers, correctional education and workforce training programs, and community‑based mentoring organizations. Secondary impacts reach substance use treatment providers, transitional housing operators, and agencies that coordinate reentry services.
Why It Matters
By widening allowable activities to include housing and explicit SUD interventions, the statute steers future grant design toward integrated reentry models. The updated authorization windows keep program authorities active for FY2026–2030, preserving the legal basis for awards but leaving funding levels to future appropriations.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill is a focused statutory clean‑up and policy tweak rather than a new standalone program. Its central change is to the State and Local Reentry Demonstration Projects provision: Congress inserts two new permissible program areas so grantees can propose and be funded for substance use disorder treatment services (the text names peer recovery services, case management, overdose education, and overdose reversal medications) and for reentry housing services.
Practically, that means an application to a reentry demonstration grant can include housing placements, short‑term transitional beds, or housing coordination activities alongside counseling and peer support.
Beyond that primary change, HB 3552 replaces a set of obsolete year ranges in several statutes so those grant authorities show authorization for fiscal years 2026 through 2030. The amendments touch grant authorities spanning family‑based substance abuse treatment, evaluation of prison and jail education methods, careers training demonstration grants, offender reentry substance abuse and criminal justice collaboration programs, and community‑based mentoring and transitional service grants to nonprofits.
The statutory edits are mechanical—they swap the old ‘‘2019–2023’’ strings (or similar lists of years) for a single continuous authorization block through 2030—so the legal authority to award those grants continues if Congress funds them.Two implementation implications follow immediately. First, grant applicants can structure project budgets to include housing and overdose‑response elements that previously may have been unclear as permissible uses.
That will likely bring housing providers and SUD treatment organizations into grant partnerships more often. Second, because the bill does not appropriate funds, continuation of these programs in practice depends on future appropriations and on OJP’s program priorities and solicitation language, which will determine how strongly the newly authorized activities are prioritized in awards.Finally, the changes are narrowly drafted and do not create new federal regulatory frameworks for housing or medication distribution; they simply allow federal reentry grant dollars to be used for those activities where consistent with existing federal rules (including health privacy and controlled‑substance regulation).
States and grantees will need to align these new permitted activities with Medicaid, SAMHSA, and DEA rules where applicable, and with existing grant reporting and compliance obligations.
The Five Things You Need to Know
Section 2976(b) of 34 U.S.C. 10631 is amended to add two explicit permissible activities for State and Local Reentry Demonstration Projects: treating substance use disorders (including peer recovery services, case management, overdose education, and overdose reversal medications) and providing reentry housing services.
The bill replaces multiple statutory year ranges (previously limited to 2019–2023 or similar lists) with a uniform authorization window of '2026 through 2030' across six grant authorities, preserving the legal basis for future awards in those programs.
Grant programs affected include: state and local reentry demonstration projects; family‑based substance abuse treatment grants; prison, jail, and juvenile educational methods evaluation grants; careers training demonstration grants under the Second Chance Act; offender reentry substance abuse and criminal justice collaboration grants; and community‑based mentoring and transitional service grants to nonprofits.
HB 3552 only amends authorization language and permitted uses; it contains no appropriations. Continued or increased funding depends on separate appropriations actions and on how DOJ/OJP frames solicitations.
The statute names specific SUD‑related activities—peer recovery services, case management, overdose education, and overdose reversal medications—giving grantees clearer authority to fund those discrete interventions under reentry project awards.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Adds SUD treatment and reentry housing to permitted reentry activities
This change inserts two new enumerated activities into the State and Local Reentry Demonstration Projects list. The bill specifies elements of ‘‘treating substance use disorders’’—peer recovery services, case management, overdose education, and overdose reversal medications—so applicants can budget for those services directly. It also adds ‘‘providing reentry housing services,’’ which is broad language that can encompass transitional beds, housing navigation, or short‑term subsidies depending on OJP guidance.
Extends authorization window for reentry demonstration grants
The bill replaces the previous authorization period string with a new range: 2026 through 2030. That is a technical authorization fix: it does not itself allocate funds, but it keeps the statutory authority active so DOJ can award grants under this program in those fiscal years subject to appropriations.
Continues family‑based substance abuse treatment grant authority
The amendment swaps the old year range in the family‑based substance abuse treatment grant statute for 2026–2030. Practically, this maintains the program’s statutory authorization so that DOJ can continue to solicit and make awards for family‑centered SUD interventions if funding is provided.
Aligns several Second Chance Act programs to the 2026–2030 authorization window
These coordinated edits bring careers training demonstration grants, offender reentry SUD/collaboration programs, community mentoring/transitional services grants, and the prison/jail youth education evaluation authority into the same authorization period. For program managers, this reduces statutory fragmentation and signals Congress’s intent to keep these discrete authorities available over the same multi‑year window.
This bill is one of many.
Codify tracks hundreds of bills on Criminal Justice across all five countries.
Explore Criminal Justice in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People returning from incarceration with substance use disorders — they gain a clearer pathway for federal grant dollars to fund peer recovery, case management, overdose education, and access to overdose reversal medications during reentry.
- Transitional housing providers and housing navigators — the explicit authorization for reentry housing services allows these organizations to partner on grant proposals and receive federal reentry grant funds for housing‑related services.
- Community‑based nonprofits and treatment providers — organizations that operate mentoring, workforce training, or treatment programs can now include SUD and housing components in reentry proposals, increasing their eligibility for grants.
Who Bears the Cost
- Department of Justice (OJP) program offices — they must update solicitations, model grant terms, compliance frameworks, and monitoring to reflect new permissible activities and to oversee medication‑related and housing expenditures.
- State and local grantees — agencies and nonprofits will face administrative work to develop housing partnerships, handle controlled‑substance policies for overdose reversal medications, and meet new reporting and compliance requirements.
- Federal budget and appropriators — the expanded permissible uses increase demand for limited appropriations; absent additional funding, prioritizing SUD and housing within these programs may displace other reentry activities.
Key Issues
The Core Tension
The central dilemma is between flexibility and accountability: broadening allowable uses (housing and explicit SUD treatment) lets grantees design integrated reentry interventions that match clients’ needs, but without new appropriations or clearer implementation guidance it risks diffusing limited funds, creating compliance headaches, and producing uneven access depending on local capacity.
The bill expands permissible programmatic activities without creating a dedicated funding stream or altering program standards. That creates an implementation gap: grantees can propose SUD and housing services, but whether those proposals are funded depends on future appropriations and on how DOJ structures priorities in solicitations.
Practically, grantees in jurisdictions with thin housing markets or limited treatment capacity may be unable to capitalize on the new permissions without additional capital or partner investments.
Operationally, adding overdose reversal medications and SUD treatment raises intersecting regulatory issues that the statute does not resolve. Grantees must comply with health‑privacy laws (including 42 CFR Part 2 for SUD records where applicable), controlled‑substance rules, and state policies on medication‑assisted treatment; they will also need to address storage, consent, and liability issues for distributing naloxone or other medications.
Finally, the statute’s broad language about ‘‘reentry housing services’’ leaves open how long housing can be supported, whether rental assistance or capital costs are allowable, and how projects will be evaluated for outcomes versus short‑term placements.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.